Hims & Hers Health (HIMS) Competitors

Hims & Hers Health (NYSE:HIMS) and Fresenius Medical Care (NYSE:FMS) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, media sentiment, earnings, dividends, analyst recommendations, community ranking, risk, valuation and institutional ownership.

Do analysts prefer HIMS or FMS?

Hims & Hers Health currently has a consensus target price of $20.71, indicating a potential upside of 7.22%. Fresenius Medical Care has a consensus target price of $24.30, indicating a potential upside of 9.56%. Given Fresenius Medical Care's higher probable upside, analysts clearly believe Fresenius Medical Care is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	1 Sell rating(s)	8 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.38
Fresenius Medical Care	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

Does the media prefer HIMS or FMS?

In the previous week, Hims & Hers Health had 26 more articles in the media than Fresenius Medical Care. MarketBeat recorded 30 mentions for Hims & Hers Health and 4 mentions for Fresenius Medical Care. Fresenius Medical Care's average media sentiment score of 0.93 beat Hims & Hers Health's score of 0.44 indicating that Fresenius Medical Care is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	10 Very Positive mention(s)	5 Positive mention(s)	9 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Fresenius Medical Care	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals and insiders believe in HIMS or FMS?

63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 8.3% of Fresenius Medical Care shares are held by institutional investors. 17.7% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Does the MarketBeat Community favor HIMS or FMS?

Fresenius Medical Care received 384 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 54.69% of users gave Fresenius Medical Care an outperform vote while only 36.73% of users gave Hims & Hers Health an outperform vote.

Company	Underperform	Outperform
Hims & Hers Health	Outperform Votes 36 36.73%	Underperform Votes 62 63.27%
Fresenius Medical Care	Outperform Votes 420 54.69%	Underperform Votes 348 45.31%

Which has more volatility and risk, HIMS or FMS?

Hims & Hers Health has a beta of 1.06, meaning that its share price is 6% more volatile than the S&P 500. Comparatively, Fresenius Medical Care has a beta of 0.91, meaning that its share price is 9% less volatile than the S&P 500.

Which has better earnings and valuation, HIMS or FMS?

Fresenius Medical Care has higher revenue and earnings than Hims & Hers Health. Fresenius Medical Care is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$1.24B	3.34	-$23.55M	$0.44	43.91
Fresenius Medical Care	$21.05B	0.62	$540.07M	$1.21	18.33

Is HIMS or FMS more profitable?

Hims & Hers Health has a net margin of 8.19% compared to Fresenius Medical Care's net margin of 3.43%. Hims & Hers Health's return on equity of 10.97% beat Fresenius Medical Care's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	8.19%	10.97%	8.29%
Fresenius Medical Care	3.43%	6.04%	2.69%

Summary

Hims & Hers Health beats Fresenius Medical Care on 11 of the 18 factors compared between the two stocks.